Free Trial

BioNexus Gene Lab (BGLC) News Today

$0.23 -0.03 (-12.80%)
(As of 12/20/2024 05:31 PM ET)
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks
BioNexus Gene Lab Faces Delisting and Leadership Changes
BioNexus partners with Vitarray for gene detection
European Central Bank cuts key interest rates as inflation falls
Cyclezyme AB (CYCLE.ST)
Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?
BioNexus Gene Lab Invests in AI Healthcare Company
Get BioNexus Gene Lab News Delivered to You Automatically

Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter.

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

BGLC Media Mentions By Week

BGLC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BGLC
News Sentiment

0.00

0.59

Average
Medical
News Sentiment

BGLC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BGLC Articles
This Week

0

1

BGLC Articles
Average Week

Get BioNexus Gene Lab News Delivered to You Automatically

Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BGLC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners